joining Han this for our financial provide recap Thank Q&A. our turn good update and for our an Han XXXX update on provide and performance everyone. us business And year. an will will today. to we and outlook. before priorities Thanks, will I you afternoon, performance on I key our
Valley a other turmoil recent with banks. has note This situation start the about impacted Silicon will Bank unfortunate and I involving many.
Let confirm not to do bank have does that of banks Amyris me that not them. either We direct with the issue. exposure
deposits. pleased Our in we in platform banks banking regions continued our to commercial with the each need We sufficient global is should that as maintain operate JPMorgan confirm we to also principal I of am capital. urgently ship have we bank. to backup working access
recently yesterday, Givaudan, As the days. the X-K secured you transaction we from made carry the may in through upfront the within capture to which seen cash from debt payment point, million should be when Amyris disclosure to can we have $XX with XX us signed XX
delivered disciplined, growth. we solid X our performance of quarter fourth with marks a and robust efficient Slide use funds that continued,
by consumer quarter fourth growth, the Our delivered XXXX. XX% quarter marked growth record second business of consecutive of over
fourth quarter the XXXX. a revenue core core single million of new over company. the quarter is revenue for up is $XX Our This total XX% of also record
Our with half about XX% consumer running partners. direct-to-consumer is business retail about and
continues growth about results business deliver of XX% DXC to strong Our with year-over-year.
invested. of good marketing progress XXXX, of making We first less dollar spend operated with are every headcount. half revenue with the for marketing and $X our our We than
of every for brands across that has with world-class and agency. of marketing significant insights for We social of every Empower, our of all is MG being across efficient and of commerce revenue come dollar from XXXX more marketing I at for to customer revenue much model dollar end innovation now support a our including our scaled teams, acquisition at This invested. $X $X expect us are invested
and executive froze we team then. during the of we simplified significant I reduction roles. quarter direct headcount, have eliminated with have headcount of reports leadership a I total XX% have fourth headcount my since confirm can lowered and we the our that our On structure
These support that and in being first filled the a working and in we are capital our sweetener, XXXX products shift. on we our Reb product end were and in for orders working farnesene-related fourth are unable was priority. use of and where mostly of the focused our of These million with customers. cash half M. We limited use quarter, liquidity. top did During very environment $XX capital not orders natural over operated to critical This the revenue, constrained also have resulted best of ingredient are
our ingredients robust. for remains very Demand
Our been are working improving has through and first of capital. access biggest these feedstock half resolved be and of Both capacity, will XXXX. challenge the to
delivering growth be participate leaders are our commitment the on we to We core revenue of the in our competitors. drive categories growth to and consumer biotech
third quarter, material million. which of We quarter We over cash third pleased the are cash to the are cash first reduction fourth and prioritizing from in This million $XXX use reduction our indication prior is the our cash of our use use. the quarter consumed quarter XXXX. of with $XX $XXX consecutive a of $XXX revenue is million of versus in million in quarterly
direct of the an fourth the quarter the basis not the of increase Consumer for is XXXX. was happening XXX of Our best over margin points quarter consumer at gross expense our of and year growth margin.
fit We win continue agenda. to execute our to broad
proprietary We sourcing transitioning and more efficient are aggressively manufacturing. to
quarter already at are our we expected of there interfaces all production than consumer of where costs around XX% in facility XXXX. the manufactured expect realizing Brazil, volume our better We by third
business deliver XX%. improved XXX actions estimated basis the margin alone, are an consumer to bestsellers cost XXX XXXX. of of Biossance points for through improvement our our expected combined to These goods by manufacturing interfaces For
often for color should and demand prestige consumer leading environment, X category healthy aging hair skincare Slide macro are our Industry line thriving quarter, we as which of of category, the accelerated economic This fourth XX% prestige over and healthy categories. participate year-over-year was the that lipstick effect, each in even beauty in. context It’s quarter. affordable care, on the us called will has spend the is a strong beauty blended uncertainty, consumers at and degree growing to broadly there in inflation a margins across and the top first indulgences. number where these be tells in we when very say assessed into data positive that is cosmetics, trend
no consumer marketing proprietary as reflected molecules of the as and You in and this can our that science-backed are through demanding and There well operate fundamentals are and consumer see business that doubt Beauty trend. on. building model reported what L’Oréal, sustainable, to in our categories. companies retail leading the consumers best and build Ulta global It’s that beauty on of is market are the of leaders market performance these our spending driver is a synergistically brands partners. us creating LVMH brands performing some differentiated Clean, enables
technology can at winning markets, where our accomplish path clearly superior replacing where that in on with non-sustainable focused best are lower end costs. to products We from is chemistry and the we sources
through with We resources their those development long-term and and we is product and own producer, where who are strategy. leverageable in end to This distribution Lab-to-Market the science our executing skills have partner markets, and reach. share we new technology, and as develop the the and leaders scale grow respective market we underlying
with we the that chemistry partners making market opportunities and are best clean, enables at Our sustainable great developing simply access are do they market and great them and their at what reach.
brands work for These as get support pillar a solid strategy, our seconds. brands, also are with in demand few adjustments, performance. from we and our which retailers with this direct-to-consumer will will X, we making to great growing consumer Slide to of the continue strategic while I doing
As compete in the mentioned, the real we strong tailwinds in with categories growth quarter. first have continued
buy level. retail like demand get it an success getting all consumer key smartly not When it’s and have this heard invest no brands, The Sephora and is supported of have from retail with healthy at Here our that drives market we the strong of. sales ingredients. we A business we marketing is time. drives BXC brands our the awareness our felt learned. just for impact is to stores growth Consumers amazing And in partners flywheel a performance. are are walking we that right, what what the investment of we more at strong of leadership. our direct-to-consumer they have efficient strategic And better brands into when shelf
our We deliver for industry-leading are accelerate consumer we committed and will this growth moderate or portfolio investment. continuing to to based on growth
and great We ingredients growing assets significant and have and brands for we our products the and produce. demand
for XXXX. ingredient capacity sold available out is Our
drive fully to and costs assets on leverage a focus portfolio. also deeper X, simplifying to enterprise value our efficiency, our our lowering Slide requires
gross can’t We growth, are extend where I which mentioned earlier. our leadership have we investments market predictable sustainable and the and narrowing increase margin includes to
clear The have year. around remain current expected XX% leaders profitability. of non-core brands in of our ingredients rationalization growth, that $XXX proceeds portfolio and this expect generate portfolio that are our revenue X additional path our of value further X a and a to current market is assets our to their end focusing brand have over brands This consumer of lot a our our to consumer million of and We $X cash in to portfolio around formulations with represent market and use billion.
further other our with we eliminate deep in reduce we buyers that parallel, dollars. limited of selling. We for In we process potential invest and are these discussions all assets in the active will of non-core are and where prioritization through divestments spend
include me an and move million. an value from products created over fermentation. the any of partnership strategic of X This the we upfront we $XXX Givaudan This first of now signed long-term $XXX leading production margin that expected million in $XXX sustainable or from to add expected $XXX the clean to Let during beauty earn-out for of million of over has partnership the of industry production joint to dollars transaction with February. agreement. years Givaudan includes future strategic million our chemistry have the from gross the development years be does over transaction XX the with in value are produced molecules paid we for This part with not cash,
than the revenue on reduction XXXX’s that there will these production We as of through we continue long-term ingredients of less agreement. the to expect basis be benefit numbers manufacturing million from the $XX
technology Xx the Hemisqualane structure BisaboLife includes both two for these in represents sustainable more ingredients, Ingredion a the is and our platform. have clean molecules for in result an Fragrance other their you & growth This sustainable uniquely value formulation This and our linguist value into is insights other market Givaudan, the our product versus and sustainable proof becoming transaction power molecules, industry. and and global powerhouse fermentation we Flavor our Givaudan’s that truly to clean, market. makes that where is strategic This than technology one from protection. the and healthy. already We our transform the screen, clear and nutrition is Reb molecule Squalane When develop products sun solution capability clear our markets beauty transaction in resources, that for with human Bio-Retinol with planet development and for transaction leader combine the transactions M chemistry with breakthrough, and transaction the positioned stack two of a partnership biotechnology a is global platform and relationship to consistent chemistry great the of in DSM excellent of
and this XX the is with Win and Givaudan in communicated, me expect to HSR expand transaction, care sustained other that XX-day to through previously current context we growth let step significant our creates I As of Fit verticals are our closing the categories Fidelity ingredients. with put the Having for beauty and go-to-market Givaudan. three development funding. waiting the new along covered long-term discussed of we through growing With our There back leadership personal to biofermentation transaction potential model. period ingredients portfolio, the our rigor, where and to
the M. come from from three expected top performing Food, expanding This doing the Flavor This excellent emerge their with are our revenue for partnership market access our beverage we growing planned. competitive also have is adjuvants. is for is And really in about Ingredion. job will the include for and in and well potential commercialization and and rate ingredients ingredients a to will relationship. in strategic XXXX process at opportunities will opportunities a markets the ingredient & are that we continue and squalene are our Fragrance excited human to outcome. faster DSM engaged vaccine the This be Reb an revenue we for to They extremely than a pharmaceutical and is health market. streams participants with blockbuster potential nutrition
venture. are in been XX, manufacturing a Slide regarding approached active and have discussions we joint
would one The with a combine opportunity this would facility assets JV of what and structure our cash about biomanufacturing are exploring have the significant Bonita the diligence biomanufacturing and of the current the facilities. partner some we quality are world’s of proposed initial producers, Barra Bonita. We of sugar next completed processing mill fund teams production our assets have and would top from we size the and impressed They built a and Barra downstream amount with four of capability. overall lease our at
the significant consumes most of cash in our a We be capital with leadership advance a Biomanufacturing and working biomanufacturing amount believe significantly approach. partnership deeply this time. market our long of cycle strategic type has and can capital-light
will this very opportunity we and on are with pleased you We update progress.
sheet $XXX in great balance million working discussions year construction financial we in next in and to end our this this facility, a to short-term is the facility best-in-class by needed capability have commitment new ingredients used we this expect is this. addition also to million fully as of biofermentation We best built structure planned, and generate then our to the and the processing. testimony and to up $XX free partnerships dedicated help be the cash world to can continue support biomanufacturing The facility. we XXX% If have opportunity our from farnesene be of In the our the and JV this the prove partner biochemical million downstream $XX in for believe of business. that current capital this funding production continue to much
– capacity, bring self-sustaining operations. proceeds With use the to We non-core opportunity rationalization million see for from clear run-rate to operating consumer in over across our $XXX over by and in and path XXXX to on cash need and of million from and XXX% We manufacturing excellence end XXXX. our the efficiency the to around brands XXXX of we generation. partner intend $XXX a the cash now focus
reduction Fit right ensuring in size the We with of are for agenda, this our and Win through rationalization portfolio delivering lean focused to have along future. our cash non-core assets organization use we supporting
also savings the expanding the through manufacturing agenda, our gross and We growth DSM has & earn-out. this the year business the Fragrance are of Givaudan the but through and to margin Flavors impact Win underlying our Fit in also on the cost earn-out this
self-sufficient actions these as growth. XXXX us to its Taken capacity meet objective enterprise to our ending a with together, we fund expect enable will of a growing
Let me out by liquidity. close our discussing
with Our on efficiency liquidity forcing challenging. best. we extremely a has been the to been It where healthy we is matters what has factor growth and as invest focused and ensure the are we
and the prepared health, world capability will cost of consumers that are To savings Amyris delivering are any summarize, the and the demanding don’t integration that markets investment company consumers model ability of value. and what to build and and today. come to develop Lab-to-Market products sells wellness profitable detailed, have who biotechnology in I market proceeds love. with and an know be beauty I on combines enterprise that are As to leading we companies Givaudan proven we
inbound We retailers for brand partnerships and have never wanting interest as had in access would and and new work to our to to needing owners much products. molecules capability us deliver with new great chemistry developing and
this disciplined visibility a year. ambitious, by operating of the operating with end is self-sustaining cash but have realistic, We flow to that XXXX plan
cost when do resources and keep We not greatest our base. be the companies customer fail least are will without into who our this continue XXXX. rightsizing the not to passionate. talented to in Last streamline They more performance have opportunities could required many to our certainly incredible grateful portfolio supplied, to scrappy, delivered while leaning full teams our but
Let the me call Han. now to turn
